IGF1 and obesity due to melanocortin 4 receptor deficiency: Obesity leads to higher levels of circulating insulin and IGF-1 in the body [14], which have been associated with risk for ER+ tumors [30] and increased mammographic density in women with BMIs < 25 kg/m2, but not in overweight and obese women [31].